The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
Origin Sciences
AstraZeneca
UMC Utrecht
Bayer
Psyence Australia Pty Ltd
ViroMissile, Inc.
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
AstraZeneca
Essen Biotech
A2 Biotherapeutics Inc.
Eli Lilly and Company
Angiex, Inc.
MacroGenics
Daiichi Sankyo
University of Nebraska
Eli Lilly and Company
Adela, Inc
National Institutes of Health Clinical Center (CC)
Imperial College London
Var2 Pharmaceuticals
MOMA Therapeutics
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Pfizer
Dana-Farber Cancer Institute
Maastricht University Medical Center
Institut Bergonié
Travera Inc
GI Innovation, Inc.
Exelixis
Senhwa Biosciences, Inc.
Jonsson Comprehensive Cancer Center
Shanghai Public Health Clinical Center
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Monopar Therapeutics
Monopar Therapeutics
Columbia University
AtlasMedx, Incorporated
Stanford University
LaunXP Biomedical Co., Ltd.
Molecure S.A.
Singlera Genomics Inc.
Centre Georges Francois Leclerc